Mohammad M Khan
Overview
Explore the profile of Mohammad M Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
990
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan M, Khan Z, Khan M
World J Psychiatry
. 2024 Jul;
14(6):767-783.
PMID: 38984346
Although significant advances have been made in understanding the patho-physiology of psychiatric disorders (PDs), therapeutic advances have not been very convincing. While psychotropic medications can reduce classical symptoms in patients...
2.
Khan M, Khan Z, Shoeb F, Fatima G, Khan R, Khan M
Int J Biol Macromol
. 2023 May;
242(Pt 2):124859.
PMID: 37187418
Patients with Alzheimer's disease (AD) display both peripheral tissue and brain insulin resistance, the later could be a potential risk factor for cognitive dysfunction. While certain degree of inflammation is...
3.
Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options
Khan M
Neurosci Biobehav Rev
. 2022 Oct;
143:104919.
PMID: 36270454
Insulin resistance may precede the onset of psychosis in schizophrenia; however, the underlying mechanism remains unclear. While certain degree of inflammation is required for triggering insulin resistance, fatty acid accumulation...
4.
Khan M
World J Psychiatry
. 2022 Aug;
12(6):827-842.
PMID: 35978970
Background: Insulin resistance (IR) and impaired energy expenditure (IEE) are irreparable metabolic comorbidities in schizophrenia. Although mechanism(s) underlying IR and IEE remains unclear, leptin and fatty acid signaling, which has...
5.
James N, Clarke N, Cook A, Ali A, Hoyle A, Attard G, et al.
Int J Cancer
. 2022 Apr;
151(3):422-434.
PMID: 35411939
Abiraterone acetate plus prednisolone (AAP) previously demonstrated improved survival in STAMPEDE, a multiarm, multistage platform trial in men starting long-term hormone therapy for prostate cancer. This long-term analysis in metastatic...
6.
Khan M, Parikh V
CNS Neurol Disord Drug Targets
. 2022 Apr;
22(2):289-303.
PMID: 35366786
Although reducing psychotic symptoms in schizophrenia has been a major focus of therapeutic interventions for decades, improving cognition is considered a better predictor of functional outcomes. However, the most commonly...
7.
Khan F, Lee J, Pham D, Khan M, Park S, Shin I, et al.
Recent Pat Nanotechnol
. 2020 Mar;
14(3):239-249.
PMID: 32167434
Background: The ability to form biofilm and produce several virulence factors has caused numerous human pathogens to become tremendously resistant towards traditional antibiotic treatments, thus, new alternative strategies are urgently...
8.
Khan M
Int J Endocrinol
. 2018 Nov;
2018:9516592.
PMID: 30402099
Accumulating data from various clinical trial studies suggests that adjuvant therapy with ovarian hormones (estrogens) could be effective in reducing cognitive deficit and psychopathological symptoms in women with psychiatric disorders....
9.
Khan F, Khan M, Kim Y
Curr Pharm Biotechnol
. 2018 Aug;
19(8):631-643.
PMID: 30152281
Background: A novel strategy has been adapted to combat the threat caused by biofilm forming-pathogenic bacteria in our environments. It involves the synthesis of antibiofilm compounds biologically (metabolites from animals,...
10.
Toro C, Hori R, Malicdan M, Tifft C, Goldstein A, Gahl W, et al.
Hum Mol Genet
. 2018 Feb;
27(7):1310.
PMID: 29447355
No abstract available.